Advertisement
Screener

Health Catalyst, Inc. (HCAT) Overview

Health Catalyst, Inc. (HCAT) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.55; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -1.53; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.32; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.59; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.95$1.21$1.53$1.95$2.47$3.142025-11-062026-11-06$0.95$2.14$4.80$10.79$24.24$54.482021-11-082026-11-06$0.95$2.19$5.04$11.61$26.73$61.572019-07-252026-11-06$0.95$2.19$5.04$11.61$26.73$61.572019-07-252026-11-06$0.95$2.19$5.04$11.61$26.73$61.572019-07-252026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.47
Previous close
$1.75
Change
-$0.28
Change (%)
-16.00%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

HCAT
-26.78%
S&P 500
(m)

1 year

HCAT
-40.07%
S&P 500
(m)

3 years

HCAT
-82.71%
S&P 500
(m)

5 years

HCAT
-96.51%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.55

-1.61-1.24-0.88-0.51-0.1431 Mar 2025: estimate (m); actual -0.3531 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.5930 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.3230 Sept 2025(m)31 Mar 2026: estimate (m); actual -1.5331 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.5530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.55(m)(m)
1 Jan 202631 Mar 2026(m)-1.53(m)(m)
1 Jul 202530 Sept 2025(m)-0.32(m)(m)
1 Apr 202530 Jun 2025(m)-0.59(m)(m)
1 Jan 202531 Mar 2025(m)-0.35(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -2.55

-3.31-2.73-2.14-1.56-0.9731 Dec 2021: estimate (m); actual -3.2331 Dec 2021(m)31 Dec 2022: estimate (m); actual -2.6331 Dec 2022(m)31 Dec 2023: estimate (m); actual -2.0931 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.1531 Dec 2024(m)31 Dec 2025: estimate (m); actual -2.5531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-2.55(m)(m)
1 Jan 202431 Dec 2024(m)-1.15(m)(m)
1 Jan 202331 Dec 2023(m)-2.09(m)(m)
1 Jan 202231 Dec 2022(m)-2.63(m)(m)
1 Jan 202131 Dec 2021(m)-3.23(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 70.49M ■ Earnings -40.54M — Profit margin -57.51%

-134.04M-157.9%-54.78M-114.7%24.48M-71.4%103.73M-28.1%30 Jun 2025: revenue 80.72M; earnings -40.98M; profit margin -50.76%30 Jun 202530 Sept 2025: revenue 76.32M; earnings -22.23M; profit margin -29.12%30 Sept 202531 Mar 2026: revenue 70.76M; earnings -111.03M; profit margin -156.91%31 Mar 202630 Jun 2026: revenue 70.49M; earnings -40.54M; profit margin -57.51%30 Jun 2026

31 Dec 2025 ■ Revenue 311.14M ■ Earnings -177.97M — Profit margin -57.20%

-236.67M-58.2%-34.50M-46.0%167.66M-33.8%369.83M-21.7%31 Dec 2022: revenue 276.24M; earnings -137.40M; profit margin -49.74%31 Dec 202231 Dec 2023: revenue 295.94M; earnings -118.15M; profit margin -39.92%31 Dec 202331 Dec 2024: revenue 306.58M; earnings -69.50M; profit margin -22.67%31 Dec 202431 Dec 2025: revenue 311.14M; earnings -177.97M; profit margin -57.20%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.47(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.47High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning HCAT

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-264.82M
Profit margin
-90.61%
Return on assets · 12 month
-54.33%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
479.18K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-7.41%*
Total return · month
10.06%*
Total return · quarter
-10.71%*
Total return · half year
59.09%*
Total return · year to date
-26.78%*
Total return · 1 year
-40.07%*
Total return · 3 years
-82.71%*
Total return · 5 years
-96.51%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$292.25M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
152.22%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Health Catalyst, Inc. Overview

View more →

(m)

(m)

SEC CIK
1636422
Industry (SIC)
7370 Services-Computer Programming, Data Processing, Etc.
Country of operation
United States
Business address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, Utah, 84095, United States
Fiscal year end
1231
Phone
801-708-6800

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eva Live Inc (GOAI)United States$0.083B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Professional Diversity Network, Inc. (IPDN)United States$0.060B
Teads Holding Co. (TEAD)United States$0.045B-0.14
Cardlytics, Inc. (CDLX)United States$0.020B-0.24
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B
ZW Data Action Technologies Inc. (CNET)$0.005B-5.46
AIRWA INC. (YYAI)United States$0.004B-101.45